» Articles » PMID: 12165455

Aneuploidy Theory Explains Tumor Formation, the Absence of Immune Surveillance, and the Failure of Chemotherapy

Overview
Date 2002 Aug 8
PMID 12165455
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The autocatalyzed progression of aneuploidy accounts for all cancer-specific phenotypes, the Hayflick limit of cultured cells, carcinogen-induced tumors in mice, the age distribution of human cancer, and multidrug-resistance. Here aneuploidy theory addresses tumor formation. The logistic equation, phi(n)(+1) = rphi(n) (1 - phi(n)), models the autocatalyzed progression of aneuploidy in vivo and in vitro. The variable phi(n)(+1) is the average aneuploid fraction of a population of cells at the n+1 cell division and is determined by the value at the nth cell division. The value r is the growth control parameter. The logistic equation was used to compute the probability distribution for values of phi after numerous divisions of aneuploid cells. The autocatalyzed progression of aneuploidy follows the laws of deterministic chaos, which means that certain values of phi are more probable than others. The probability map of the logistic equation shows that: 1) an aneuploid fraction of at least 0.30 is necessary to sustain a population of cancer cells; and 2) the most likely aneuploid fraction after many population doublings is 0.70, which is equivalent to a DNA(index)=1.7, the point of maximum disorder of the genome that still sustains life. Aneuploidy theory also explains the lack of immune surveillance and the failure of chemotherapy.

Citing Articles

Congenital Aneuploidy in Klinefelter Syndrome with B-Cell Acute Lymphoblastic Leukemia Might Be Associated with Chromosomal Instability and Reduced Telomere Length.

Kjeldsen E Cancers (Basel). 2022; 14(9).

PMID: 35565445 PMC: 9136641. DOI: 10.3390/cancers14092316.


Cancer heterogeneity: converting a limitation into a source of biologic information.

Rubben A, Araujo A J Transl Med. 2017; 15(1):190.

PMID: 28886708 PMC: 5591523. DOI: 10.1186/s12967-017-1290-9.


The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer.

Almassalha L, Bauer G, Chandler J, Gladstein S, Szleifer I, Roy H Cancer Res. 2016; 76(19):5605-5609.

PMID: 27550448 PMC: 5084919. DOI: 10.1158/0008-5472.CAN-16-0585.


Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.

Ganguly S, Home T, Yacoub A, Kambhampati S, Shi H, Dandawate P Oncotarget. 2015; 6(31):31767-79.

PMID: 26397138 PMC: 4741638. DOI: 10.18632/oncotarget.5167.


Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer.

Coward J, Harding A Front Oncol. 2014; 4:123.

PMID: 24904834 PMC: 4033620. DOI: 10.3389/fonc.2014.00123.